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An issue relevant to scientificintegrity has arisen in connec-
tion with a court case in the
Amazon, wherein the Amazonian
people are seeking redress for envi-
ronmental damage and deleterious
health effects related to the opera-
tions of Texaco in the Amazon
region of Ecuador. It has been esti-
mated that in its more than 20 years
of oil exploitation in Ecuador
(1971–1992), Texaco discharged
into the environment 16.8 million
gallons of crude oil and 20 billion
gallons of toxic wastes.1 The envi-
ronmental damage caused by
Texaco can be compared to 10.8
million gallons of crude oil spilled
in Alaska in the Exxon Valdez
tanker disaster in 1989. Moreover,
six hundred open pits filled with
toxic waste were apparently left in
the surrounding communities in
Ecuador.2,3 In 1995, the company
signed an agreement with Ecua-
dor’s government to undertake
cleanup activities in return for
releasing the company from future
responsibility related to its former
oil operations.4
On February 10, 2005, during
the ongoing court proceedings,
major newspapers in Ecuador ran a
full-page (presumably paid) adver-
tisement citing reports by scientists
retained by Texaco who critiqued
studies published in prestigious
peer-reviewed journals that suggest
links between adverse health effects
and oil development in the
Amazon.5–10 Texaco’s consultant
scientists, Kenneth Rothman, Felix
Arellano, Alvaro Felipe Dávalos
Pérez, Lowell Sever, David J. Hewitt,
and Laura Green, pointed to
alleged weaknesses in the pub-
lished studies. The ad was, to us, a
blatant effort by the company to
sway public opinion as the legal
case was being heard. The Web site
is available at: <http://www.texaco.
com/sitelets/ecuador/en/legal_
tial adverse human health and envi-
ronmental effects. If this did not
occur, should we not be asking “why
not”? In many jurisdictions, envi-
ronmental health impact assess-
ments are now required—putting
the onus where it belongs: on those
who are responsible for the poten-
tial health impacts. In fact, environ-
mental health impact assessments
are increasingly addressing not only
direct (toxicologic), but also indi-
rect impacts of development proj-
ects (health effects mediated by
changes in ecologic and social sys-
tems).11,12 Texaco’s Web site main-
tains that the primary causes of dis-
ease in the region are poverty, poor
sanitation, naturally occurring bac-
teria and parasites, a lack of access
to clean water, and insufficient
infrastructure, adding that, “it is
both irresponsible and inaccurate
for the plaintiffs to ignore these
well-documented conditions.” Yet
nowhere does Texaco mention how
oil development has conceivably
altered these conditions, nor does it
state that such conditions increase
vulnerability to the environmental
exposures of concern. Responsible
environmental health scientists,
cognizant of the need to assess indi-
rect as well as direct health effects of
operations such as these, would
have raised these issues in an open
and comprehensive discussion. 
Texaco’s protagonists, whether or
not they agree about the adverse
health impacts of the social and eco-
logic disruptions related to the oil
company’s operations, can hardly
believe that the agents involved in
drilling, and in the extracted oil, are
innocuous. The hired experts never
referred to industrial and environ-
mental exposure records, so pre-
sumably either the company failed
to collect and maintain these data or
the containment of the toxic agents
was ineffective, and therefore not
mentioned. The consultants com-
missioned by Texaco might have
reasonably been expected to note
that in the light of the monitoring,
control, and mitigating measures
provided to them by the company
archives/press/2005-02-02_health_
news.asp>.
Epidemiologic studies, however
meticulously conducted, may have
inherent limitations, as all epidemi-
ologists are aware. Epidemiology is
not laboratory science but a study
of the real world, and thus always
subject to challenge in its ability to
control for all potential effects.
Especially in vulnerable study pop-
ulations, exact details of the popu-
lations at risk, as well as the extents,
natures, and durations of expo-
sures, are difficult to document,
and ascertainment of outcomes is
limited by the quality of health
services available. 
However, epidemiologic find-
ings can confidently detect trends,
and it is the body of evidence that
should influence policy. The scien-
tific process of peer review ascer-
tains whether the potential weak-
nesses of any study raise doubts
sufficient to preclude publication
of its findings and conclusions.
Texaco’s consultants went to great
pains to find flaws in the studies.
Some of the so-called weaknesses
they point out are not even them-
selves of particular concern, e.g.,
while “memory bias of respon-
dents” may be a confounder in
some circumstances, it is hardly a
factor in the case of remembering
pregnancy and spontaneous abor-
tion. Self-reported health effects—
of which they also seem to question
the validity—is a widely used and
accepted practice.
The onus cannot be put on sci-
entists to ensure that data are avail-
able to evaluate adverse health
impacts. It is far more logical to
require a company extracting min-
erals or biological raw materials to
accept responsibility, as good corpo-
rate citizens, for determining what
protective measures it would be
prudent to impose, and to monitor
its success in controlling poten-
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there would have been no reason
for the populations to have experi-
enced any disease excesses. Their
failure to allude to the control meas-
ures instituted by Texaco certainly
raises questions. 
Scientists welcome illumination
of scientific limitations, particularly
for the purposes of promoting
better studies. However, the place to
air legitimate scientific concerns
about the quality of published
research is in the research literature
itself, wherein the critiques them-
selves would be subject to peer
review. The original authors then
have the opportunity to respond to
the critiques in an environment of
open scientific dialogue and
scrutiny by scientists internationally.
When this is not done, as has hap-
pened in this case, the public may
be seriously misled. We encourage
our colleagues to submit their cri-
tiques of published studies to the
scientific literature, not to indus-
tries that may be assumed to have
vested interests in gainsaying incon-
venient scientific evidence, such as
Texaco’s apparent interest in pro-
tecting itself by undermining the
Amazonian people’s quest for envi-
ronmental justice. 
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ANNOUNCEMENT
European Asbestos Conference in Belgium
The use of asbestos was banned in all 25 Member States of the European Union
as of January 1, 2005. Unfortunately, the repercussions of a hundred years of
widespread asbestos use remain in contaminated national infrastructures, the
environment, and the lungs of European men and women. It has been esti-
mated that in the current 35-year period, a quarter of a million men could die
in Western Europe from mesothelioma, a type of cancer caused by exposure to
asbestos. These deaths are occurring in countries many of which had regula-
tions to minimize hazardous occupational exposures. How much worse will the
death toll be in those countries, such as many of the new Member States, where
such regulations did not exist or were poorly enforced?
A European Asbestos Conference, which is being organized by the GUE, a con-
sortium of European left-wing political parties, and the International Ban
Asbestos Secretariat (IBAS) will take place September 22 and 23, 2005, in the
European Parliament in Brussels. The objectives of this event include: increas-
ing politicians’ (especially MEPs from the new Member States) awareness of
asbestos-related problems, exploring options for pressing European multina-
tionals to: adopt corporate codes against using asbestos in their worldwide oper-
ations and establish codes of practice for dealing with asbestos products in their
infrastructures, and examining strategies and planning future initiatives.
For more information contact Laurie Kazan-Allen, IBAS Coordinator, by e-mail:
<laurie@lkaz.demon.co.uk>.
